| Autor: |
Morillo-Verdugo, Ramón, Aguilar Pérez, Tamara, Gimeno-Gracia, Mercedes, Rodríguez-González, Carmen, Robustillo-Cortes, María de las Aguas, Robustillo-Cortes, María de las Aguas, Uranga, Aitziber Illaro, López, Alicia Lázaro, Crespo, Angels Andreu, Alarcón, Aránzazu Linares, Vega, Beatriz Proy, García, Belén López, Solanes, Carlos Seguí, Rodríguez-González, Carmen, Guisado, Carolina Aguilar, García, Elena Cárdaba, Cuadrado, Emilio Molina, Boquet, Emilio Monte, Lecha, Encarna Abad, Escrig, Esther Vicente, Orfila, Gabriel Mercadal, Aznárez, Herminia Navarro, López, Inmaculada Nacle, Orbis, Irene Cañamares, Anciano, Jara Gallardo, Arrate, Javier Casas, Ferrández, Javier Sánchez-Rubio, López, Joaquín Ignacio Serrano, Pedrosa, José Alberto Peña, González, Jose Sebastián Roldan, Lisón, Luis Carlos Fernández, Framinan, Luis Margusino, Valín, Luis Ortega, Martin, Maite, Vélez, Manuel, Crespo, María Ángeles Andreu, Maria, Maria Carmen Rosado, Coronel, María García, Fernández, Maria Jose Huertas, Gimeno-Gracia, Mercedes, García, Mercedes Manzano, Peña, Noelia Garrido, Atorrasagasti, Oihana Mora, Fenollera, Patricia Sanmartin, Ruíz, Pilar Díaz, Elcano, Ramón San Miguel, Molina, Raquel Fresquet, del Águila, Vera Áreas, Rebollo-Gómez, Dr Elena, Marfil, Dr Vanessa |
| Zdroj: |
The Annals of Pharmacotherapy; 20220101, Issue: Preprints |
| Abstrakt: |
Background People living with human immunodeficiency virus (HIV) require specific pharmaceutical care (PC). Although the 2017 Capacity-Motivation-Opportunity (CMO) PC model allows a multidisciplinary approach that focuses on patient needs, it is too complex and presents room for improvement.Objective The aim of this study is to simplify and adapt the previous 2017 PC tool through a multidimensional approach to improve HIV patient care, to prove the validity of the model in real-life patients.Methods The new PC tool was generated by keeping some of the variables of the 2017 document and conducting a literature search. Content validity was determined by a 2-round Delphi methodology with an expert panel of 42 pharmacists. Consensus for the first and second rounds was defined as ≥70% agreement. The tool generated was validated in 407 real-life patients.Results Thirty-seven experts completed the first round of the Delphi survey and 36 the second. No consensus was reached for 3 variables, any of the frequency options and 4 interventions, while the experts agreed not to include 1 intervention in round 1. Consensus to include them was found for all but 1 variable and 1 intervention in round 2. The final tool obtained to select and stratify HIV-positive patients was composed of 9 dimensions divided into 17 variables. The new tool was validated with real-life patients and 3 priority levels were defined.Conclusions and relevance We created a new pyramid of score thresholds to classify patients into priority levels. The new tool simplifies the 2017 model and improves its utility to help HIV-positive patients, owing to its multidimensional approach. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
